EMBOLIZATION MARKET ANALYSIS

The high cost of biomarkers treatment procedures can hamper the global embolization market growth. Embolization procedures such as tumor embolization require the use of expensive medical devices and equipment. Due to various factors like advanced technologies involved, high manufacturing costs of these devices, specialized training required by physicians and long hospital stay times, the overall cost of embolization significantly adds to the economic burden on patients. This escalating cost of accessing these specialized treatment options can restrict their uptake, especially in developing regions and among lower-income groups in developed markets. According to the data published by WHO in 2022, over 100 million people worldwide are pushed into extreme poverty each year due to health expenses. The high out-of-pocket spending on specialized procedures denies equitable access to quality healthcare for all.

 Market Opportunities: Advancements in embolization devices

Advancements in embolization devices can offer opportunities for global embolization market. Embolization procedures are minimally invasive techniques that is used to block blood vessels or abnormalities to cut off blood flow to an area of the body. Traditionally, embolization devices involved coils, liquid embolic agents and vascular plugs. However, emerging technologies allows clinicians to treat more complex conditions with minimally invasive therapies. Newly developed microspheres, beads, plugs and spacers are enabling physicians to embolize difficult to access vascular spaces and small target vessels with improved control, precision and efficacy compared to traditional options. This makes embolization procedures suitable for more complex cases and expands the range of treatable conditions.